Room 515, Xisihuan Middle Road NO.100,
Beijing, 100039
China
Occult Hepatitis C, Direct-Acting Antiviral Agents, Liver Fibrosis, HCV Relapse
hepatitis E; liver failure; predictors; chronic liver disease
sodium taurocholate cotransporting polypeptide (NTCP); hepatocyte proliferation; Hepatitis B virus (HBV) infection; Chronic Hepatitis B (CHB); antiviral therapy; p53; S-phase kinase associated protein 2 (SKP2); cyclin D1